-
-
-
-
-
Pulmonary Fibrosis Treatment With Nebulized Prodrug HIF2-Antagonists
This technology focuses on developing HIF2 inhibitors to enhance adaptive lung repair for targeted pulmonary fibrosis treatment. The follow-on award will advance this system, which leverages endogenous bioactivation.
-
-
Developing an AI Platform to Provide Point-of-Care Educational Decision Support (EDS) to Academic Medical Centers (AMCs):
VLRChat is an AI chatbot that answers clinical questions using retrieval-augmented generation on peer-reviewed medical content. The follow-on award will support the development of xLR, an interoperable multi-institutional platform.
-
-
From Prototype to Clinical Platform
Finalizing BRILLIANCE for Individualized Noninvasive Brain Stimulation,” Bioscience and Healthcare: BRILLIANCE is an automated MRI-EEG fusion pipeline that identifies the location and timing of individual brain activations. The follow-on award will facilitate integration of structural brain…
-
